𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon α treatment

✍ Scribed by Diarmuid S Manning; Katherine M Sheehan; Michael F Byrne; Elaine W Kay; Frank E Murray

Book ID
108951327
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
198 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Side effects of α interferon in chronic
Side effects of α interferon in chronic hepatitis C
✍ G Dusheiko 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Alpha interferon is available worldwide as at least six dif-Alpha interferons have been used widely to treat chronic hepatitis C virus infection. These include recombinant inter-ferent products made by as many pharmaceutical companies. It is approved for human use in the European Union and the fero

Cost effectiveness of interferon α2b com
Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C
✍ Zobair M. Younossi; Mendel E. Singer; John G. McHutchison; Kenneth M. Shermock 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Treatment of chronic hepatitis C with Interferon (IFN) ␣2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated

Cost-effectiveness of interferon alfa 2b
Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th